Featured Insights

  1. Insights From Pharma 2025: Leadership In Pharma – Empowering Change Through Innovative Thinking 6/12/2025

    What does it take to lead in today's evolving pharmaceutical landscape? Insights from Pharma 2025 reveal that empowering teams through trust, experimentation, and a shared purpose is key.

  2. Inclusion Of Health-Related Quality Of Life (HRQoL) And Other Patient-Reported Outcomes (PROs) In FDA Labels 6/12/2025

    With a growing emphasis on patient-centric drug development, new research examines how frequently patient-reported outcomes are actually making it onto United States Food and Drug Administration labels.

  3. Value Of Multi-Indication Immunotherapies For The Treatment Of Autoimmune Diseases In The United States 6/12/2025

    As multi-indication therapies become more common, new research questions their value. A study for ISPOR 2025 reveals a potential misalignment between the price and value of these versatile treatments.

  4. Impact Of JCA And Project Orbis On The European Revenue Potential Of An Oncology Product 6/12/2025

    Contrary to concerns about price erosion, new analysis suggests Joint Clinical Assessment and Project Orbis will likely increase European oncology product revenue by enabling faster market uptake.

  5. Creating A Compliant And Scalable CGT Logistics Launch Plan 6/12/2025

    As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.